[go: up one dir, main page]

MX2014003051A - Composiciones para el tratamiento de ulceras perifericas de diversos origenes. - Google Patents

Composiciones para el tratamiento de ulceras perifericas de diversos origenes.

Info

Publication number
MX2014003051A
MX2014003051A MX2014003051A MX2014003051A MX2014003051A MX 2014003051 A MX2014003051 A MX 2014003051A MX 2014003051 A MX2014003051 A MX 2014003051A MX 2014003051 A MX2014003051 A MX 2014003051A MX 2014003051 A MX2014003051 A MX 2014003051A
Authority
MX
Mexico
Prior art keywords
treatment
peripheral
ulceras
compositions
ulcers
Prior art date
Application number
MX2014003051A
Other languages
English (en)
Other versions
MX347245B (es
Inventor
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of MX2014003051A publication Critical patent/MX2014003051A/es
Publication of MX347245B publication Critical patent/MX347245B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a combinaciones de un agente que estimula la proliferación celular y un anti-inflamatorio/analgésic o, que resultan útiles para el tratamiento de úlceras periféricas de diversos orígenes, tales como dermatitis por radiación, úlceras diabéticas, úlceras causadas por éxtasis venosa de los miembros, escaras, y las infecciones cutáneas que se les asocian, proctitis, vulvovaginitis y hemorroides con lesiones vasculares; estas combinaciones se pueden presentar como formulaciones para uso tópico.
MX2014003051A 2011-09-16 2012-09-13 Composiciones para el tratamiento de úlceras periféricas de diversos orígenes. MX347245B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001671A ITMI20111671A1 (it) 2011-09-16 2011-09-16 Composizioni per il trattamento di ulcere periferiche di varia origine
PCT/EP2012/067893 WO2013037859A1 (en) 2011-09-16 2012-09-13 Compositions for the treatment of peripheral ulcers of various origins

Publications (2)

Publication Number Publication Date
MX2014003051A true MX2014003051A (es) 2014-04-10
MX347245B MX347245B (es) 2017-04-19

Family

ID=44907960

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014003051A MX347245B (es) 2011-09-16 2012-09-13 Composiciones para el tratamiento de úlceras periféricas de diversos orígenes.

Country Status (21)

Country Link
US (3) US9278084B2 (es)
EP (1) EP2755670B1 (es)
JP (1) JP6026540B2 (es)
KR (1) KR101996319B1 (es)
CN (1) CN103874499B9 (es)
AR (1) AR087879A1 (es)
AU (1) AU2012307406B2 (es)
BR (1) BR112014005966A2 (es)
CA (1) CA2848570C (es)
DK (1) DK2755670T3 (es)
ES (1) ES2577405T3 (es)
HU (1) HUE028120T2 (es)
IL (1) IL231498B (es)
IT (1) ITMI20111671A1 (es)
MX (1) MX347245B (es)
PL (1) PL2755670T3 (es)
PT (1) PT2755670E (es)
RU (1) RU2619853C2 (es)
SG (1) SG11201400617UA (es)
SI (1) SI2755670T1 (es)
WO (1) WO2013037859A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201690021A1 (ru) * 2013-07-14 2016-08-31 Асирос А/С Алкалоидные композиции из вида ribes для лечения состояний, связанных с функцией митохондрий или ингибированием pde4, pde5 и ikk-бета
CN103961482A (zh) * 2014-04-23 2014-08-06 湖州康企药业有限公司 一种治疗皮炎的天然药物
ITUB20160672A1 (it) * 2016-02-11 2017-08-11 Mireno Leoni Composizione farmaceutica per il trattamento della disidrosi
KR101892865B1 (ko) 2017-08-16 2018-08-28 계명대학교 산학협력단 마퀴베리를 유효성분으로 함유하는 아토피성 피부염 예방 또는 치료용 조성물

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1589294A (en) * 1976-09-08 1981-05-13 Inverni Della Beffa Spa Pharmaceutical compositions containing anthocyanidines
US4376781A (en) * 1978-02-27 1983-03-15 Inverni Della Beffa S.P.A. Pharmaceutical compositions
GB8518289D0 (en) * 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2
IT1231725B (it) * 1989-08-11 1991-12-21 Inverni Della Beffa Spa Procedimento per la preparazione di estratti ad alto contenuto in antocianosidi.
EP0464298B1 (en) * 1990-07-05 1995-06-21 INDENA S.p.A. Echinacea extracts, a process for the preparation thereof and formulations containing them
IT1255029B (it) * 1992-05-11 1995-10-13 Paolo Morazzoni Formulazioni farmaceutiche orali contenenti antocianosidi
IT1270602B (it) * 1994-07-12 1997-05-07 Indena Spa Formulazioni a base di esculoside e loro uso in campo farmaceutico e cosmetico
US6224871B1 (en) * 1998-03-11 2001-05-01 Reliv International, Inc. Dietary supplement for nutritionally promoting healthy joint function
CA2421109C (en) * 2000-08-31 2011-05-03 Hauser, Inc. Efficient method for producing compositions enriched in anthocyanins
NZ515182A (en) * 2001-10-31 2004-03-26 Brightwater Horticulture Ltd Extraction of biologically active compounds from plant material using acid and antioxidant
US20030152610A1 (en) * 2002-01-28 2003-08-14 David Rolf Cosmetic patch
US8337914B2 (en) * 2002-02-27 2012-12-25 Access Business Group International Llc Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
RU2203082C1 (ru) * 2002-07-22 2003-04-27 Государственное учреждение Тверская государственная медицинская академия Способ лечения язвенно-эрозивных поражений гастродуоденальной зоны в сочетании с артериальной гипертензией
ITMI20032287A1 (it) * 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento delle affezioni del cavo orale e delle prime vie respiratorie
ITMI20042414A1 (it) * 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
TWI286941B (en) * 2005-07-27 2007-09-21 Anagen Therapeutics Inc Stabilized pharmaceutical and cosmetic composition of catechins or derivatives thereof
GB2428952B (en) 2005-07-30 2010-10-06 Hewlett Packard Development Co Digital pen and paper system
US7763289B2 (en) * 2005-09-01 2010-07-27 JoAl's Products, LLC Topical turmeric skin care products
US7303772B2 (en) * 2005-11-10 2007-12-04 Olalde Rangel Jose Angel Synergistic phytoceutical compositions
EP1882473A1 (en) * 2006-07-28 2008-01-30 Indena S.P.A. Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs
WO2010011541A2 (en) * 2008-07-22 2010-01-28 Izun Pharmaceuticals, Inc. Topical anti-inflammatory combination

Also Published As

Publication number Publication date
US20170035826A1 (en) 2017-02-09
SG11201400617UA (en) 2014-05-29
CA2848570C (en) 2020-12-22
CN103874499A (zh) 2014-06-18
IL231498A0 (en) 2014-04-30
WO2013037859A1 (en) 2013-03-21
KR101996319B1 (ko) 2019-07-04
IL231498B (en) 2018-01-31
US20160058812A1 (en) 2016-03-03
SI2755670T1 (sl) 2016-07-29
PL2755670T3 (pl) 2016-11-30
US9278084B2 (en) 2016-03-08
KR20140067045A (ko) 2014-06-03
US20140220165A1 (en) 2014-08-07
PT2755670E (pt) 2016-06-20
AR087879A1 (es) 2014-04-23
US10149877B2 (en) 2018-12-11
RU2619853C2 (ru) 2017-05-18
EP2755670B1 (en) 2016-05-11
CA2848570A1 (en) 2013-03-21
CN103874499B9 (zh) 2018-09-21
JP2014526487A (ja) 2014-10-06
AU2012307406A1 (en) 2014-04-03
BR112014005966A2 (pt) 2017-04-04
JP6026540B2 (ja) 2016-11-16
ITMI20111671A1 (it) 2013-03-17
HUE028120T2 (en) 2016-11-28
RU2014109796A (ru) 2015-09-20
AU2012307406B2 (en) 2016-11-17
ES2577405T3 (es) 2016-07-14
US9526716B2 (en) 2016-12-27
CN103874499B (zh) 2018-07-27
MX347245B (es) 2017-04-19
DK2755670T3 (en) 2016-08-15
EP2755670A1 (en) 2014-07-23

Similar Documents

Publication Publication Date Title
GT201500051A (es) Inhibidores de glucosilceramida sintasa
MX376008B (es) Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide.
GT201300215A (es) Inhibidores de glucosilceramida sintasa
BR112016011024A2 (pt) Composto, composição farmacêutica, e, usos dos mesmos
ECSP14017269A (es) Compuestos para tratar la atrofia muscular espinal
MX2019010601A (es) Terapia de combinacion para tratar cancer.
PL2444081T3 (pl) Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol
GT201500081A (es) Derivados de exendina-4 como agonistas duales de glp1/glucagón
CR20120596A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
EA201500448A1 (ru) Гуанидиновое соединение
CO6710926A2 (es) Compuestos de n-heteroarilo
MX341300B (es) Composiciones para el tratamiento de ulceras perifericas de varios origenes.
MX2020008031A (es) Composiciones y metodos para reducir el contenido de alcohol en sangre.
MX376183B (es) Composiciones para el tratamiento de rosacea.
CO7141430A2 (es) Formulaciones vesiculares para uso en el tratamiento del dolor o movilidad reducida de una articulación
ECSP14000606A (es) Agentes inductores de la apoptosis que pueden usarse para tratar el cáncer y las enfermedades inmunes y autoinmunes
BR112016000350A8 (pt) métodos de tratamento de lesões inflamatórias da rosácea e usos de uma composição farmacêutica
EA201691032A1 (ru) Производные изохромена в качестве ингибиторов фосфоинозитид-3-киназ
CO6710913A2 (es) Uso de ácido lipasa lisosomal para tratar la deficiencia de ácido lipasa lisosomal en pacientes
BR112013020159A2 (pt) método para inibir células tumorais de hamartoma
BR112014030534A2 (pt) composições de galacto-ramnogalacturonato para o tratamento de doenças associadas com óxido nítrico sintase induzível elevada
IN2014KN02914A (es)
MX2014003051A (es) Composiciones para el tratamiento de ulceras perifericas de diversos origenes.
BR112015000616A2 (pt) tratamento da esclerose múltipla com combinação de laquinimode e fampridina
EA201492154A1 (ru) Косметическая и/или фармацевтическая композиция для лечения воспаления кожи и связанных синдромов

Legal Events

Date Code Title Description
FG Grant or registration